PIK3CA and melanoma: We and others have investigated PI3K inhibitors in patients with melanoma brain metastases.17,18,32 Preclinical data showed that the treatment with buparlisib is highly effective in preclinical models of melanoma brain metastases from patient-derived cell lines to xenograft mouse models.